The Paramount Syntex IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 30 September 2026. The Paramount Syntex IPO closed on 6 October 2026, with an issue price of ₹127 per share. The Paramount Syntex IPO has a face value of ₹10 and a lot size of 1,000 shares. The Paramount Syntex IPO size aggregates up to ₹82 crore, listing on BSE SME on 9 October 2026. The Paramount Syntex IPO allotment was scheduled for 7 October 2026.
On the financial front, the Paramount Syntex IPO reported revenue of ₹123 crore for 31 Mar 2026, compared with ₹113 crore for 31 Mar 2025. The Paramount Syntex IPO PAT was ₹14 crore against ₹7 crore. The Paramount Syntex IPO EBITDA stood at ₹24 crore with a 19.33% margin. The Paramount Syntex IPO net worth as of 31 Mar 2026 was ₹43 crore.
Always verify The Paramount Syntex IPO details and GMP data with the official offer document before investing in the Paramount Syntex IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
96
76
60
Revenue
123
113
93
PAT
14
7
1
EBITDA
24
13
9
Net Worth
43
29
14
Reserves
31
17
3
Total Borrowing
33
33
33
Paramount Syntex IPO Financials FAQs
Revenue of Paramount Syntex (Amount in ₹ Crore) — 31 Mar 2026: 123; 31 Mar 2025: 113; 31 Mar 2024: 93. Profit after tax (PAT) — 31 Mar 2026: 14; 31 Mar 2025: 7; 31 Mar 2024: 1.
EBITDA of Paramount Syntex (Amount in ₹ Crore) — 31 Mar 2026: 24; 31 Mar 2025: 13; 31 Mar 2024: 9. The EBITDA margin is 19.33%.
Total assets — 31 Mar 2026: 96; 31 Mar 2025: 76; 31 Mar 2024: 60. Net worth — 31 Mar 2026: 43; 31 Mar 2025: 29; 31 Mar 2024: 14. Reserves & surplus — 31 Mar 2026: 31; 31 Mar 2025: 17; 31 Mar 2024: 3. (Amount in ₹ Crore)
Total borrowing of Paramount Syntex (Amount in ₹ Crore) — 31 Mar 2026: 33; 31 Mar 2025: 33; 31 Mar 2024: 33. Debt-to-equity ratio: 0.78.
The financials shown for Paramount Syntex IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.